LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,256 | -48.8% | 36,015 | +7.5% | 0.00% | – |
Q2 2023 | $76,685 | +680.2% | 33,487 | +727.9% | 0.00% | – |
Q1 2023 | $9,829 | +22.0% | 4,045 | -4.1% | 0.00% | – |
Q4 2022 | $8,054 | -26.8% | 4,217 | -9.1% | 0.00% | – |
Q3 2022 | $11,000 | -64.5% | 4,637 | -72.0% | 0.00% | – |
Q2 2022 | $31,000 | +72.2% | 16,553 | +90.8% | 0.00% | – |
Q1 2022 | $18,000 | -80.6% | 8,676 | -63.2% | 0.00% | – |
Q4 2021 | $93,000 | +116.3% | 23,607 | +164.2% | 0.00% | – |
Q3 2021 | $43,000 | -18.9% | 8,935 | -22.9% | 0.00% | – |
Q2 2021 | $53,000 | +165.0% | 11,595 | +234.1% | 0.00% | – |
Q1 2021 | $20,000 | -93.6% | 3,471 | -96.2% | 0.00% | – |
Q4 2020 | $314,000 | +109.3% | 91,887 | -11.8% | 0.00% | – |
Q3 2020 | $150,000 | +525.0% | 104,183 | +751.7% | 0.00% | – |
Q2 2020 | $24,000 | -33.3% | 12,233 | -34.2% | 0.00% | – |
Q1 2020 | $36,000 | -53.8% | 18,603 | -1.5% | 0.00% | – |
Q4 2019 | $78,000 | -49.7% | 18,888 | -63.3% | 0.00% | – |
Q3 2019 | $155,000 | -83.9% | 51,493 | -66.3% | 0.00% | -100.0% |
Q2 2019 | $960,000 | +9.5% | 152,624 | -3.1% | 0.00% | 0.0% |
Q1 2019 | $877,000 | -68.5% | 157,539 | -62.5% | 0.00% | -66.7% |
Q4 2018 | $2,787,000 | -11.4% | 419,644 | +42.3% | 0.00% | 0.0% |
Q3 2018 | $3,147,000 | +18.0% | 294,857 | +32.6% | 0.00% | +50.0% |
Q2 2018 | $2,668,000 | +326.9% | 222,386 | +204.8% | 0.00% | – |
Q1 2018 | $625,000 | -27.7% | 72,953 | -16.6% | 0.00% | -100.0% |
Q4 2017 | $864,000 | -34.9% | 87,458 | -19.0% | 0.00% | 0.0% |
Q3 2017 | $1,328,000 | +60.0% | 107,992 | +114.1% | 0.00% | 0.0% |
Q2 2017 | $830,000 | -43.3% | 50,430 | -50.6% | 0.00% | 0.0% |
Q1 2017 | $1,463,000 | -40.3% | 102,011 | -42.4% | 0.00% | -50.0% |
Q4 2016 | $2,450,000 | +6.6% | 177,100 | +39.3% | 0.00% | 0.0% |
Q3 2016 | $2,298,000 | +1072.4% | 127,109 | +830.2% | 0.00% | – |
Q2 2016 | $196,000 | -61.4% | 13,665 | -67.9% | 0.00% | -100.0% |
Q1 2016 | $508,000 | +535.0% | 42,526 | +604.8% | 0.00% | – |
Q4 2015 | $80,000 | -85.5% | 6,034 | -88.2% | 0.00% | -100.0% |
Q3 2015 | $550,000 | +362.2% | 51,253 | +246.5% | 0.00% | – |
Q2 2015 | $119,000 | – | 14,793 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |